Jarl Hellman

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Nyström, Thomas; Schwarz, Erik; Dahlqvist, Sofia; Wijkman, Magnus et al.

Ingår i Journal of Diabetes Science and Technology, s. 89-98, 2024

• DOI för Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)
• Ladda ner fulltext (pdf) av Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Lind, Marcus; Catrina, Sergiu-Bogdan; Ekberg, Neda R.; Gerward, Sofia et al.

Ingår i Diabetes Therapy, s. 1563-1575, 2023

• DOI för Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study
• Ladda ner fulltext (pdf) av Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms

Cederblad, Lars; Eklund, Gustav; Vedal, Amund; Hill, Henrik et al.

Ingår i Diabetes Therapy, s. 953-965, 2023

• DOI för Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms

Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

Pylov, Daniel; Polonsky, William; Imberg, Henrik; Holmer, Helen et al.

Ingår i Journal of Diabetes Science and Technology, 2023

• DOI för Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial
• Ladda ner fulltext (pdf) av Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)

Olafsdottir, Arndis F.; Bolinder, Jan; Heise, Tim; Polonsky, William et al.

Ingår i Diabetes, obesity and metabolism, s. 619-630, 2021

• DOI för The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)
• Ladda ner fulltext (pdf) av The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)

Endokrinologi

Hellman, Jarl

Ingår i Kliniska färdigheter. Mötet mellan patient och läkare, s. 159-173, Studentlitteratur AB, 2021

Sustained Intensive Treatment and Long-term Effects on HbA(1c) Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Lind, Marcus; Olafsdottir, Arndis F.; Hirsch, Irl B.; Bolinder, Jan et al.

Ingår i Diabetes Care, s. 141-149, 2021

• DOI för Sustained Intensive Treatment and Long-term Effects on HbA(1c) Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Tekniska innovationer i diabetesvården

Hellman, Jarl

Ingår i Diabetes, s. 419-428, Studentlitteratur AB, 2020

Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen

Adolfsson, Peter; Hartvig, Niels Væver; Kaas, Anne; Møller, Jonas Bech et al.

Ingår i Diabetes Technology & Therapeutics, s. 709-718, 2020

• DOI för Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen
• Ladda ner fulltext (pdf) av Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen

The Association Between HbA_1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Seyed Ahmadi, Shilan; Westman, Klara; Pivodic, Aldina; Ólafsdóttir, Arndís F et al.

Ingår i Diabetes Care, s. 2017-2024, 2020

• DOI för The Association Between HbA_1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Treating diabetes with islet transplantation: Lessons learnt from the Nordic network for clinical islet transplantation

von Zur-Mühlen, Bengt; Scholz, Hanne; Hellman, Jarl; Korsgren, Olle et al.

Ingår i Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas, s. 599-611, Academic Press, 2019

• DOI för Treating diabetes with islet transplantation: Lessons learnt from the Nordic network for clinical islet transplantation

EPA: en modell för att träna och bedöma dagligt läkarjobb

Rosengren, Björn; Möller, Riitta; Hellman, Jarl; Jood, Katarina et al.

Ingår i Läkartidningen, 2019

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Olafsdottir, Arndis F.; Polonsky, William; Bolinder, Jan; Hirsch, Irl B. et al.

Ingår i Diabetes Technology & Therapeutics, s. 274-284, 2018

• DOI för A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
• Ladda ner fulltext (pdf) av A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial

Lind, Marcus; Polonsky, William; Hirsch, Irl B.; Heise, Tim et al.

Ingår i Journal of the American Medical Association (JAMA), s. 379-387, 2017

• DOI för Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial

Impact of continuous subcutaneous insulin infusion on diabetes related complications and associated costs in type 2 diabetes patients in sweden

Roze, S.; Duteil, E.; Delbaere, A.; De Portu, S. et al.

Ingår i Diabetes Technology & Therapeutics, 2016

Cost savings associated with CSII therapy compared to MDI in a Swedish setting

Brandt, A. -S; de Portu, S.; Hellman, Jarl

Ingår i Diabetologia, 2015

Inctretin-based treatment of diabetes realted to cystic fibrosis: a case study

Hellman, Jarl; Fischier, Johan; Hollsing, Annika

Ingår i Journal of Cystic Fibrosis, 2014

• DOI för Inctretin-based treatment of diabetes realted to cystic fibrosis: a case study
• Ladda ner fulltext (pdf) av Inctretin-based treatment of diabetes realted to cystic fibrosis: a case study

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Nyström, Thomas; Schwarz, Erik; Dahlqvist, Sofia; Wijkman, Magnus et al.

Ingår i Journal of Diabetes Science and Technology, s. 89-98, 2024

• DOI för Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)
• Ladda ner fulltext (pdf) av Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Sterner Isaksson, Sofia; Imberg, Henrik; Hirsch, Irl B.; Schwarcz, Erik et al.

Ingår i Diabetologia, s. 1517-1526, 2024

• DOI för Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
• Ladda ner fulltext (pdf) av Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes

Hellman, Jarl; Væver Hartvig, Niels; Kaas, Anne; Bech Møller, Jonas et al.

Ingår i Diabetes, obesity and metabolism, s. 301-310, 2024

• DOI för Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes
• Ladda ner fulltext (pdf) av Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes

Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Lind, Marcus; Catrina, Sergiu-Bogdan; Ekberg, Neda R.; Gerward, Sofia et al.

Ingår i Diabetes Therapy, s. 1563-1575, 2023

• DOI för Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study
• Ladda ner fulltext (pdf) av Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms

Cederblad, Lars; Eklund, Gustav; Vedal, Amund; Hill, Henrik et al.

Ingår i Diabetes Therapy, s. 953-965, 2023

• DOI för Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms

Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Nyström, Thomas; Schwarz, Erik; Dahlqvist, Sofia; Wijkman, Magnus et al.

Ingår i Journal of Diabetes Science and Technology, s. 89-98, 2024

• DOI för Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)
• Ladda ner fulltext (pdf) av Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8)

Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Sterner Isaksson, Sofia; Imberg, Henrik; Hirsch, Irl B.; Schwarcz, Erik et al.

Ingår i Diabetologia, s. 1517-1526, 2024

• DOI för Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials
• Ladda ner fulltext (pdf) av Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials

Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes

Hellman, Jarl; Væver Hartvig, Niels; Kaas, Anne; Bech Møller, Jonas et al.

Ingår i Diabetes, obesity and metabolism, s. 301-310, 2024

• DOI för Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes
• Ladda ner fulltext (pdf) av Associations of bolus insulin injection frequency and smart pen engagement with glycaemic control in people living with type 1 diabetes

Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Lind, Marcus; Catrina, Sergiu-Bogdan; Ekberg, Neda R.; Gerward, Sofia et al.

Ingår i Diabetes Therapy, s. 1563-1575, 2023

• DOI för Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study
• Ladda ner fulltext (pdf) av Fast-Acting Insulin Aspart in Patients with Type 1 Diabetes in Real-World Clinical Practice: A Noninterventional, Retrospective Chart and Database Study

Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms

Cederblad, Lars; Eklund, Gustav; Vedal, Amund; Hill, Henrik et al.

Ingår i Diabetes Therapy, s. 953-965, 2023

• DOI för Classification of Hypoglycemic Events in Type 1 Diabetes Using Machine Learning Algorithms

Entrustable professional activities (EPAs) for undergraduate medical education: development and exploration of social validity

Gummesson, Christina; Alm, Stina; Cederborg, Anna; Ekstedt, Mattias et al.

Ingår i BMC Medical Education, 2023

• DOI för Entrustable professional activities (EPAs) for undergraduate medical education: development and exploration of social validity
• Ladda ner fulltext (pdf) av Entrustable professional activities (EPAs) for undergraduate medical education: development and exploration of social validity

Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

Pylov, Daniel; Polonsky, William; Imberg, Henrik; Holmer, Helen et al.

Ingår i Journal of Diabetes Science and Technology, 2023

• DOI för Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial
• Ladda ner fulltext (pdf) av Treatment Satisfaction and Well-Being With CGM in People With T1D: An Analysis Based on the GOLD Randomized Trial

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)

Olafsdottir, Arndis F.; Bolinder, Jan; Heise, Tim; Polonsky, William et al.

Ingår i Diabetes, obesity and metabolism, s. 619-630, 2021

• DOI för The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)
• Ladda ner fulltext (pdf) av The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)

Sustained Intensive Treatment and Long-term Effects on HbA(1c) Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Lind, Marcus; Olafsdottir, Arndis F.; Hirsch, Irl B.; Bolinder, Jan et al.

Ingår i Diabetes Care, s. 141-149, 2021

• DOI för Sustained Intensive Treatment and Long-term Effects on HbA(1c) Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen

Adolfsson, Peter; Hartvig, Niels Væver; Kaas, Anne; Møller, Jonas Bech et al.

Ingår i Diabetes Technology & Therapeutics, s. 709-718, 2020

• DOI för Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen
• Ladda ner fulltext (pdf) av Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen

The Association Between HbA_1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Seyed Ahmadi, Shilan; Westman, Klara; Pivodic, Aldina; Ólafsdóttir, Arndís F et al.

Ingår i Diabetes Care, s. 2017-2024, 2020

• DOI för The Association Between HbA_1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

EPA: en modell för att träna och bedöma dagligt läkarjobb

Rosengren, Björn; Möller, Riitta; Hellman, Jarl; Jood, Katarina et al.

Ingår i Läkartidningen, 2019

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Olafsdottir, Arndis F.; Polonsky, William; Bolinder, Jan; Hirsch, Irl B. et al.

Ingår i Diabetes Technology & Therapeutics, s. 274-284, 2018

• DOI för A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)
• Ladda ner fulltext (pdf) av A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial

Lind, Marcus; Polonsky, William; Hirsch, Irl B.; Heise, Tim et al.

Ingår i Journal of the American Medical Association (JAMA), s. 379-387, 2017

• DOI för Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections The GOLD Randomized Clinical Trial

Impact of continuous subcutaneous insulin infusion on diabetes related complications and associated costs in type 2 diabetes patients in sweden

Roze, S.; Duteil, E.; Delbaere, A.; De Portu, S. et al.

Ingår i Diabetes Technology & Therapeutics, 2016

Cost savings associated with CSII therapy compared to MDI in a Swedish setting

Brandt, A. -S; de Portu, S.; Hellman, Jarl

Ingår i Diabetologia, 2015

Inctretin-based treatment of diabetes realted to cystic fibrosis: a case study

Hellman, Jarl; Fischier, Johan; Hollsing, Annika

Ingår i Journal of Cystic Fibrosis, 2014

• DOI för Inctretin-based treatment of diabetes realted to cystic fibrosis: a case study
• Ladda ner fulltext (pdf) av Inctretin-based treatment of diabetes realted to cystic fibrosis: a case study

Endokrinologi

Hellman, Jarl

Ingår i Kliniska färdigheter. Mötet mellan patient och läkare, s. 159-173, Studentlitteratur AB, 2021

Tekniska innovationer i diabetesvården

Hellman, Jarl

Ingår i Diabetes, s. 419-428, Studentlitteratur AB, 2020

Treating diabetes with islet transplantation: Lessons learnt from the Nordic network for clinical islet transplantation

von Zur-Mühlen, Bengt; Scholz, Hanne; Hellman, Jarl; Korsgren, Olle et al.

Ingår i Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas, s. 599-611, Academic Press, 2019

• DOI för Treating diabetes with islet transplantation: Lessons learnt from the Nordic network for clinical islet transplantation